Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer

NCT03589950 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Lung Neoplasms
Docetaxel
Pemetrexed
S-1
Anlotinib

Interventions

DRUG: anlotinib plus chemotherapy
DRUG: chemotherapy

Sponsor

The First People's Hospital of Lianyungang

Collaborators

[object Object]